Abstract
A 76-year-old man with proved small-cell and non-small-cell lung cancer and symptoms of a paraneoplastic syndrome, including a heliotrope rash; scaly erythematous rash over the face, neck, and upper torso; proximal muscle weakness; and creatine kinase elevation, underwent F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) as part of a work-up to detect (mediastinal) lymph nodes or distant metastases.
| Original language | English |
|---|---|
| Pages (from-to) | 58-59 |
| Number of pages | 2 |
| Journal | Clinical nuclear medicine |
| Volume | 28 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 2003 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- F-18 Fluorodeoxyglucose
- Non-Small-Cell Lung Cancer
- Paraneoplastic Syndrome
- Polymyositis Dermatomyositis
- Positron Emission Tomography
Fingerprint
Dive into the research topics of 'Accessory Findings on F-18 FDG Positron Emission Tomography in Bronchogenic Carcinoma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver